{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:19:25Z","timestamp":1791001165133,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ymgme.2014.09.004","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T04:49:36Z","timestamp":1410842976000},"page":"281-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis"],"prefix":"10.1016","volume":"114","author":[{"given":"Brian R.","family":"Vuillemenot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarmi","family":"Sri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thom","family":"Doeleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin L.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan R.","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayle C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall P.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald G.","family":"Musson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Henshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Keve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea","family":"Cahayag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie S.","family":"Tsuruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2014.09.004_bb0005","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ymgme.2006.02.016","article-title":"A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis","volume":"89","author":"Awano","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0010","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s11095-013-1062-z","article-title":"Preclinical models used for immunogenicity prediction of therapeutic proteins","volume":"30","author":"Brinks","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.brainresrev.2010.08.002","article-title":"Recent insights into a new hydrodynamics of the cerebrospinal fluid","volume":"65","author":"Bulat","year":"2011","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0192623310391679","article-title":"Morphologic changes associated with intrathecal catheters for direct delivery to the central nervous system in preclinical studies","volume":"39","author":"Butt","year":"2011","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0025","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/mt.2008.9","article-title":"Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Chang","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0030","series-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","first-page":"80","article-title":"CLN2","author":"Chang","year":"2011"},{"issue":"7","key":"10.1016\/j.ymgme.2014.09.004_bb0035","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1523\/JNEUROSCI.19-07-02556.1999","article-title":"Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment","volume":"19","author":"Cooper","year":"1999","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.ymgme.2014.09.004_bb0045","first-page":"60ra89","article-title":"Replacing the enzyme alpha-l-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I","volume":"1","author":"Dierenfeld","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ymgme.2011.07.004","article-title":"An individually, modified approach to desensitize infants and young children with Pompe disease, and significant reactions to alglucosidase alfa infusions","volume":"104","author":"El-Gharbawy","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0055","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1177\/0192623311409595","article-title":"Safety evaluation of chronic intrathecal administration of idursulfase-IT in cynomolgus monkeys","volume":"39","author":"Felice","year":"2011","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0060","doi-asserted-by":"crossref","first-page":"31058","DOI":"10.1074\/jbc.M400700200","article-title":"Maturation of human tripeptidyl-peptidase I in vitro","volume":"279","author":"Golabek","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"Pt 3","key":"10.1016\/j.ymgme.2014.09.004_bb0065","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","article-title":"The efficiency of systematic sampling in stereology and its prediction","volume":"147","author":"Gundersen","year":"1987","journal-title":"J. Microsc."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0070","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbamcr.2008.11.004","article-title":"Neuronal ceroid lipofuscinoses","volume":"1793","author":"Jalanko","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2014.09.004_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.23423","article-title":"Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease)","author":"Katz","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0080","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/iovs.08-1712","article-title":"Retinal pathology in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"49","author":"Katz","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.ymgme.2014.09.004_bb0085","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nbd.2006.09.001","article-title":"Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"25","author":"Kielar","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0090","first-page":"63","article-title":"Nursing management of patients with an implanted Ommaya reservoir","volume":"3","author":"Kosier","year":"1999","journal-title":"Clin. J. Oncol. Nurs."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/humu.21624","article-title":"Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses","volume":"33","author":"Kousi","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0100","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/pbc.25080","article-title":"Safety profile of long-term intraventricular access devices in pediatric patients receiving radioimmunotherapy for central nervous system malignancies","volume":"61","author":"Kramer","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ymgme.2014.09.004_bb0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/bj3570049","article-title":"Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis","volume":"357","author":"Lin","year":"2001","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.ymgme.2014.09.004_bb0110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ymgme.2009.07.001","article-title":"Desensitization of an adult patient with Pompe disease and a history of anaphylaxis to alglucosidase alfa","volume":"98","author":"Lipinski","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0115","series-title":"Handbook of Veterinary Neurology","author":"Lorenz","year":"2011"},{"key":"10.1016\/j.ymgme.2014.09.004_bb0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jb\/mvi110","article-title":"Catalytic residues and substrate specificity of recombinant human tripeptidyl peptidase I (CLN2)","volume":"138","author":"Oyama","year":"2005","journal-title":"J. Biochem."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0125","first-page":"691","article-title":"New strategies for the treatment of lysosomal storage diseases","volume":"5","author":"Parenti","year":"2013","journal-title":"Int. J. Mol. Med."},{"issue":"7","key":"10.1016\/j.ymgme.2014.09.004_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1743-8454-7-9","article-title":"The function and structure of the cerebrospinal fluid outflow system","volume":"21","author":"Pollay","year":"2010","journal-title":"Cerebrospinal Fluid Res."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0135","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1601-183X.2011.00718.x","article-title":"A reversal learning task detects cognitive deficits in a Dachshund model of late-infantile neuronal ceroid lipofuscinosis","volume":"10","author":"Sanders","year":"2011","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0140","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3171\/2013.3.PEDS12397","article-title":"Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis","volume":"11","author":"Selden","year":"2013","journal-title":"J. Neurosurg. Pediatr."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0145","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","article-title":"Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis","volume":"277","author":"Sleat","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2014.09.004_bb0150","first-page":"15","article-title":"Optimal use of the Ommaya reservoir in clinical oncology","volume":"3","author":"Sundaresan","year":"1989","journal-title":"Oncology"},{"key":"10.1016\/j.ymgme.2014.09.004_bb0155","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ymgme.2011.03.011","article-title":"Biodistribution and pharmacodynamics of recombinant human alpha-l-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations","volume":"103","author":"Vite","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.taap.2014.03.005","article-title":"Recombinant human tripeptidyl peptidase-1 infusion to the monkey CNS: safety, pharmacokinetics, and distribution","volume":"277","author":"Vuillemenot","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0165","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ymgme.2011.06.018","article-title":"Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"104","author":"Vuillemenot","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0170","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.exer.2014.06.008","article-title":"Enzyme replacement therapy delays pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"125C","author":"Whiting","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6807-3-8","article-title":"A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases","volume":"3","author":"Wlodawer","year":"2003","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0180","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2008.022","article-title":"Treatment of late infantile neuronal carotid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA","volume":"19","author":"Worgall","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16390","article-title":"The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders","volume":"16","author":"Wyatt","year":"2012","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.ymgme.2014.09.004_bb0190","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1007\/s00018-012-0957-x","article-title":"The cerebrospinal fluid: regulator of neurogenesis, behavior, and beyond","volume":"69","author":"Zappaterra","year":"2012","journal-title":"Cell. Mol. Life Sci."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214002935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214002935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T00:55:41Z","timestamp":1565830541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719214002935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1096719214002935"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.09.004","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}